Clinical trial / 1999
Early reductions in muscle glucose-6-phosphate suggest free fatty acids primarily inhibit glucose transport/phosphorylation before whole-body uptake declines.
In seven healthy men, skeletal muscle metabolism was tracked via 31P nuclear magnetic resonance spectroscopy during euglycemic-hyperinsulinemic clamps under high, basal, and low free fatty acid (FFA) levels. Whole-body glucose uptake was approximately 20% lower after 140 minutes with basal and high FFAs (42.8 +/- 3.6 and 41.6 +/- 3.3 vs. control 52.7 +/- 3.3 micromol x kg(-1) x min(-1), P < 0.05). Intramuscular glucose-6-phosphate (G-6-P) was blunted at 45 minutes of high FFA exposure (184 +/- 17 vs. control: 238 +/- 17 micromol/l, P = 0.008) and remained lower at 180 minutes with high and basal FFAs versus control (P < 0.05). The authors conclude these early G-6-P patterns suggest FFAs primarily inhibit glucose transport/phosphorylation prior to reducing whole-body glucose disposal.
- Study type
- Euglycemic-hyperinsulinemic clamp trial
- Who was studied
- Seven healthy men
- What was measured
- Skeletal muscle glucose-6-phosphate, Pi, pH, and whole-body glucose uptake
THE PAPER
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhäusl W. Diabetes, 1999.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.